Compositions and methods of administering tubulin binding agents for the treatment of ocular diseases

Details for Australian Patent Application No. 2004296805 (hide)

Owner Oxigene, Inc.

Inventors Wood, Mark; Sherris, David

Agent Cullen & Co

Pub. Number AU-A-2004296805

PCT Pub. Number WO2005/056018

Priority 10/732,680 09.12.03 US

Filing date 3 December 2004

Wipo publication date 23 June 2005

International Classifications

A61K 31/66 (2006.01) - Phosphorus compounds

Event Publications

20 July 2006 PCT application entered the National Phase

  PCT publication WO2005/056018 Priority application(s): WO2005/056018

30 June 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004296810-Active suture for the delivery of therapeutic fluids

2004296804-Methods and compositions for autism risk assessment